EHE in Action

In 2019, the U.S. Department of Health and Human Services (HHS), through CDC, awarded $16.5 million to state and local health departments to build the foundation for Ending the HIV Epidemic (EHE) and set the United States on a path for progress. A key part of that effort was providing $12 million for the development of state and local EHE plans to guide implementation in each of the 57 priority jurisdictions. Plans were submitted in December 2020 and are currently being finalized.

Additionally, CDC used HHS Minority HIV/AIDS funds to invest a total of $4.5 million in three “Jumpstart Sites” to implement key foundational activities that will help accelerate progress toward ending the HIV epidemic in their communities. The successes and lessons learned from these sites will be shared to support nationwide EHE efforts. From July to December 2019, Jumpstart Sites implemented and accelerated key EHE strategies in their communities, including:

East Baton Rouge Parish, LA
  1. Established HIV and hepatitis testing in an emergency department
  2. Increased the HIV testing capacity of five community-based organizations
  3. Hired five community health workers and a rapid-start navigator to reach out to the communities most impacted
DeKalb County, GA
  1. Initiated a jail-based HIV testing program and trained 30 nurses to deliver HIV testing in jails
  2. Provided same-day linkage to care and treatment for those newly diagnosed during targeted outreach testing
  3. Provided access to PrEP* to clients in two new clinics and utilized online marketing to promote PrEP in the areas of the county that are most in need
Baltimore City, MD
  1. Incorporated HIV/STD testing into a mobile syringe-services program (SSP)
  2. Implemented a care navigation and treatment program in two clinics to improve viral suppression
  3. Provided access to PrEP* to clients in two health centers

Additionally, CDC funding for these jumpstart sites supported an effort to scale up HIV prevention services in specialty STD clinics pdf icon[PDF – 1.7 MB, 2 pages].


* Pre-exposure prophylaxis (PrEP) is a daily pill taken to prevent HIV

Page last reviewed: April 1, 2021